Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2017

• Founders

  • Sri Kosuri
  • Ramsey Homsany

  LUX Partners

  • Adam Goulburn

• Latest Tweets

  • Michael Truell, wrote a blog post about the first @OctantBio internship: working with bits and atoms during his CO… https://t.co/pt3Zfd93XD@OctantBio - 03:44 PM Sep 9th
  • Its the first day with our new synbio apprentices! The SBAs go through a "training project" their first month that… https://t.co/BzG5oiAaX6@OctantBio - 04:17 PM Aug 3rd